Shakil S

References (19)

Title : Molecular interaction of inhibitors with human brain butyrylcholinesterase - Shakil_2021_EXCLI.J_20_1597
Author(s) : Shakil S
Ref : EXCLI J , 20 :1597 , 2021
Abstract :
PubMedSearch : Shakil_2021_EXCLI.J_20_1597
PubMedID: 35024017

Title : Molecular interaction of anti-cancer ligands with human brain acetylcholinesterase - Shakil_2020_J.Biomol.Struct.Dyn__1
Author(s) : Shakil S
Ref : J Biomol Struct Dyn , :1 , 2020
Abstract :
PubMedSearch : Shakil_2020_J.Biomol.Struct.Dyn__1
PubMedID: 33089743

Title : In silico screening of glycogen synthase kinase-3beta targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease - Jabir_2020_J.Biomol.Struct.Dyn__1
Author(s) : Jabir NR , Shakil S , Tabrez S , Khan MS , Rehman MT , Ahmed BA
Ref : J Biomol Struct Dyn , :1 , 2020
Abstract :
PubMedSearch : Jabir_2020_J.Biomol.Struct.Dyn__1
PubMedID: 32588759

Title : Molecular interaction of investigational ligands with human brain acetylcholinesterase - Shakil_2019_J.Cell.Biochem__
Author(s) : Shakil S
Ref : Journal of Cellular Biochemistry , : , 2019
Abstract :
PubMedSearch : Shakil_2019_J.Cell.Biochem__
PubMedID: 30746750

Title : Silver nanoparticles from leaf extract of Mentha piperita: Eco-friendly synthesis and effect on acetylcholinesterase activity - Khatoon_2018_Life.Sci_209_430
Author(s) : Khatoon A , Khan F , Ahmad N , Shaikh S , Rizvi SMD , Shakil S , Al-Qahtani MH , Abuzenadah AM , Tabrez S , Ahmed ABF , Alafnan A , Islam H , Iqbal D , Dutta R
Ref : Life Sciences , 209 :430 , 2018
Abstract :
PubMedSearch : Khatoon_2018_Life.Sci_209_430
PubMedID: 30138593

Title : Molecular Interaction of Anti-Diabetic Drugs With Acetylcholinesterase and Sodium Glucose Co-Transporter 2 - Shakil_2017_J.Cell.Biochem_118_3855
Author(s) : Shakil S
Ref : Journal of Cellular Biochemistry , 118 :3855 , 2017
Abstract :
PubMedSearch : Shakil_2017_J.Cell.Biochem_118_3855
PubMedID: 28387957

Title : Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses - Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820
Author(s) : Kamal MA , Shakil S , Nawaz MS , Yu QS , Tweedie D , Tan Y , Qu X , Greig NH
Ref : CNS Neurol Disord Drug Targets , 16 :820 , 2017
Abstract :
PubMedSearch : Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820
PubMedID: 28176640

Title : Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy - Rizvi_2016_Neurochem.Res_41_1475
Author(s) : Rizvi SM , Shaikh S , Naaz D , Shakil S , Ahmad A , Haneef M , Abuzenadah AM
Ref : Neurochem Res , 41 :1475 , 2016
Abstract :
PubMedSearch : Rizvi_2016_Neurochem.Res_41_1475
PubMedID: 26886763

Title : Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders - Shaikh_2016_Biotechnol.Appl.Biochem_63_145
Author(s) : Shaikh S , Rizvi SM , Shakil S , Riyaz S , Biswas D , Jahan R
Ref : Biotechnol Appl Biochem , 63 :145 , 2016
Abstract :
PubMedSearch : Shaikh_2016_Biotechnol.Appl.Biochem_63_145
PubMedID: 25402624

Title : Prediction of Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study - Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
Author(s) : Shaikh S , Rizvi SM , Suhail T , Shakil S , Abuzenadah AM , Anis R , Naaz D , Dallol A , Haneef M , Ahmad A , Choudhary L
Ref : CNS Neurol Disord Drug Targets , 15 :1216 , 2016
Abstract :
PubMedSearch : Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
PubMedID: 27697060

Title : A neuroinformatics study to compare inhibition efficiency of three natural ligands (Fawcettimine, Cernuine and Lycodine) against human brain acetylcholinesterase - Shaikh_2015_Network_26_25
Author(s) : Shaikh S , Zainab T , Shakil S , Rizvi SM
Ref : Network , 26 :25 , 2015
Abstract :
PubMedSearch : Shaikh_2015_Network_26_25
PubMedID: 25611730

Title : A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity - Baig_2014_CNS.Neurol.Disord.Drug.Targets_13_265
Author(s) : Baig MH , Rizvi SM , Shakil S , Kamal MA , Khan S
Ref : CNS Neurol Disord Drug Targets , 13 :265 , 2014
Abstract :
PubMedSearch : Baig_2014_CNS.Neurol.Disord.Drug.Targets_13_265
PubMedID: 24059317

Title : Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study - Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447
Author(s) : Rizvi SM , Shakil S , Biswas D , Shaikh S , Bagga P , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :447 , 2014
Abstract :
PubMedSearch : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447
PubMedID: 24059302

Title : Current acetylcholinesterase-inhibitors: a neuroinformatics perspective - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391
Author(s) : Shaikh S , Verma A , Siddiqui S , Ahmad SS , Rizvi SM , Shakil S , Biswas D , Singh D , Siddiqui MH , Tabrez S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :391 , 2014
Abstract :
PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391
PubMedID: 24059296

Title : Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach - Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
Author(s) : Alam A , Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Imran M , Haneef M , Abuzenadah AM , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :487 , 2014
Abstract :
PubMedSearch : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
PubMedID: 24059299

Title : Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452
Author(s) : Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Tabrez S , Akhtar S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :452 , 2014
Abstract :
PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452
PubMedID: 24059300

Title : Molecular interaction of the antineoplastic drug, methotrexate with human brain acetylcholinesterase: a docking study - Shakil_2012_CNS.Neurol.Disord.Drug.Targets_11_142
Author(s) : Shakil S , Kamal MA , Tabrez S , Abuzenadah AM , Chaudhary AG , Damanhouri GA
Ref : CNS Neurol Disord Drug Targets , 11 :142 , 2012
Abstract :
PubMedSearch : Shakil_2012_CNS.Neurol.Disord.Drug.Targets_11_142
PubMedID: 22483282

Title : Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study - Shakil_2011_CNS.Neurol.Disord.Drug.Targets_10_845
Author(s) : Shakil S , Khan R , Tabrez S , Alam Q , Jabir NR , Sulaiman MI , Greig NH , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 10 :845 , 2011
Abstract :
PubMedSearch : Shakil_2011_CNS.Neurol.Disord.Drug.Targets_10_845
PubMedID: 21999734

Title : Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach - Al-Jafari_2011_CNS.Neurol.Disord.Drug.Targets_10_928
Author(s) : Al-Jafari AA , Shakil S , Reale M , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 10 :928 , 2011
Abstract :
PubMedSearch : Al-Jafari_2011_CNS.Neurol.Disord.Drug.Targets_10_928
PubMedID: 22229321